Sun.Jun 02, 2024

article thumbnail

The USTR “Watch List” Designation You Will Never See

Hugh Stephens Blog

Image: Shutterstock (AI Assisted) In my last blog post, I discussed the annual Special 301 Report issued by the Office of the US Trade Representative (USTR).

Designs 100
article thumbnail

At last: Habemus Covidiot!

The IPKat

After it was referred back in 2021, a few days ago the Grand Board of the European Union Intellectual Property Office finally issued its long-awaited decision concerning an application to register the figurative sign ‘COVIDIOT’ (below) as an EU trade mark for the following goods: Class 6: Metal clips. Class 9: Computer gaming software; Mobile apps. Class 28: Board games; Toys.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IP.com Launches IQ Ideas+ 3.0: Revolutionizing Ideation with AI-Powered Innovation to Maximize ROI in R&D

IP.com

Press Release: 6/2/2024 Engineering leadership must embrace AI in the innovation process. Rochester, June 3 – IP.com is excited to unveil IQ Ideas+ 3.0, featuring Compass AI , a revolutionary new solution that transforms enterprise ideation and problem-solving, delivering enhanced ROI. Utilizing cutting-edge generative artificial intelligence (AI), Compass AI offers a structured approach to creativity, intelligently guiding users through a structured approach to explore, refine, and deve

article thumbnail

The Devil Made Me Do It: When are USPTO Filings ‘Involuntary’?

IP Watchdog

In Dragon Intellectual Property LLC v. Dish Network LLC, - (Fed. Cir., May 20, 2024), a divided panel of the U. S. Court of Appeals for the Federal Circuit held that a prevailing defendant in an otherwise “exceptional” patent infringement case could not recover attorney fees expended in a parallel inter partes review (IPR) proceeding because the defendant’s initiation of the IPR was “voluntary.

article thumbnail

Software Composition Analysis: The New Armor for Your Cybersecurity

Speaker: Blackberry, OSS Consultants, & Revenera

Software is complex, which makes threats to the software supply chain more real every day. 64% of organizations have been impacted by a software supply chain attack and 60% of data breaches are due to unpatched software vulnerabilities. In the U.S. alone, cyber losses totaled $10.3 billion in 2022. All of these stats beg the question, “Do you know what’s in your software?

article thumbnail

€5.3m Pirate IPTV Network ‘Dismantled’ By Spanish Police is Still Streaming

TorrentFreak

A press release issued by Spain’s Ministry of the Interior on Friday initially sounds straightforward. Based on a complaint filed by the Alliance for Creativity and Entertainment, in November 2022 an investigation was launched to identify those responsible for two websites that marketed a service that allegedly violated the rights of ACE members. “The complex computer and banking investigation carried out, together with several police investigation techniques, allowed the specialists

Reporting 104
article thumbnail

Open AI’s vison for a social contract – of things to come…

Kluwer Copyright Blog

Photo by Jonathan Kemper on Unsplash On 7 May 2024, Open AI published its approach to data and AI (ADAI). This statement sets out OpenAI’s vison for a ‘social contract for content in AI’. In this vision, OpenAI shares its own perception of its contribution to creative ecosystems, but also its understanding of some of the legal implications of its business model.

More Trending

article thumbnail

Out to launch

Likelihood of Confusion

The glamour of the jet age! It can only get better when LIKELIHOOD OF CONFUSION® touches down soon at #INTA2015! pic.twitter.com/aG7AA7YDGT — Likelihood TM Blog (@likely2confuse) May 3, 2015 Originally posted 2015-05-03 11:08:21. Republished by Blog Post Promoter The post Out to launch appeared first on LIKELIHOOD OF CONFUSION™.

article thumbnail

The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22)

The IPKat

The recent Board of Appeal case T 0209/22 is yet another decision demonstrating the relatively permissive approach in Europe to medical use inventions. The patent related to the medical use of a combination of known drugs. The claim was supported by data described in the application from a phase I clinical trial in healthy volunteers. The patent did not include any patient data for the drug combination.

article thumbnail

Goodbye Rosen references, hello Jennings references?

Patently-O

Guest Post by Sarah Burstein, Professor of Law at Suffolk University Law School LKQ Corp. v. GM Global Tech. , 21-2348 (Fed. Cir. 2024) (en banc). In its decision in LKQ v. GM , the en banc Federal Circuit may have raised as many questions as it answered. For now, I’d like to focus on one: What counts as a proper primary reference under LKQ ? While the Federal Circuit overruled the Rosen requirement that a primary reference look “basically the same” as the claimed design, the court did not over

Art 45